Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death
Elena V. Sazonova, Maria A. Yapryntseva, Nikolay V. Pervushin, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 388-388
Open Access | Times Cited: 11

Showing 11 citing articles:

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 7
Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
Zhiyong Long, Yanfang Luo, Min Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Nanocurcumin: A new and improved way to fight cancer and infections
Kokkarachedu Varaprasad, S. Natarajan, Tippabattini Jayaramudu, et al.
Nano-Structures & Nano-Objects (2024) Vol. 40, pp. 101352-101352
Closed Access | Times Cited: 3
The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: biological mechanisms and future potential
Alireza Mafi, Neda Hedayati, Yaser Eshaghi Milasi, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155457-155457
Closed Access | Times Cited: 1
BH3-mimetics or DNA-damaging agents in combination with RG7388 overcome p53 mutation-induced resistance to MDM2 inhibition
Nikolay V. Pervushin, Dmitry K. Nilov, Sergey V. Pushkarev, et al.
APOPTOSIS (2024)
Open Access | Times Cited: 1
Design and Synthesis of a Novel Pyrazole-Based Molecule with Potential Anticancer and Antimicrobial effects: A Multifaceted in silico Approach
Rengarajan Kavitha, S. Prabhu, Nagamuthu Prakash, et al.
Journal of Molecular Structure (2024), pp. 140536-140536
Closed Access | Times Cited: 1
Up to the Herculean Task of Tackling Cancer Therapy Resistance
Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Cancers (2024) Vol. 16, Iss. 10, pp. 1826-1826
Open Access
The m-TORC1 inhibitor Sirolimus increases the effectiveness of Photodynamic therapy in the treatment of cutaneous Squamous Cell Carcinoma, impairing NRF2 antioxidant signaling
Jimena Nicolás-Morala, Marta Mascaraque, María Gallego-Rentero, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 11, pp. 4238-4257
Open Access
Cisplatin Resistance and Metabolism: Simplification of Complexity
Nikolay V. Pervushin, Maria A. Yapryntseva, Mikhail A. Panteleev, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3082-3082
Open Access
Synthesis, characterization, biological activity, and modelling protein docking of divalent, trivalent, and tetravalent metal ion complexes of new azo dye ligand (N,N,O) derived from benzimidazole
Ali M. Taher, Hussein Ali Kadhim Kyhoiesh, Azal Shakir Waheeb, et al.
Results in Chemistry (2024) Vol. 12, pp. 101911-101911
Open Access
Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells
Sachin Bhardwaj, Sanjay, Ajay K. Yadav
Journal of Neuro-Oncology (2024)
Closed Access
Page 1

Scroll to top